Point72 Asset Management’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18.4M | Buy |
8,084,623
+5,434,623
| +205% | +$12.3M | 0.04% | 445 |
|
|
2025
Q1 | $1.68M | Hold |
2,650,000
| – | – | ﹤0.01% | 817 |
|
|
2024
Q4 | $2.73M | Buy |
+2,650,000
| New | +$2.73M | 0.01% | 756 |
|
|
2022
Q3 | – | Sell |
-2,750,000
| Closed | -$5.03M | – | 1087 |
|
|
2022
Q2 | $5.03M | Sell |
2,750,000
-1,621,300
| -37% | -$2.97M | 0.02% | 607 |
|
|
2022
Q1 | $11.7M | Sell |
4,371,300
-1,931,725
| -31% | -$5.16M | 0.05% | 428 |
|
|
2021
Q4 | $27.3M | Hold |
6,303,025
| – | – | 0.11% | 264 |
|
|
2021
Q3 | $32.1M | Sell |
6,303,025
-90,875
| -1% | -$463K | 0.14% | 185 |
|
|
2021
Q2 | $40.5M | Buy |
6,393,900
+58,900
| +0.9% | +$373K | 0.18% | 137 |
|
|
2021
Q1 | $49M | Buy |
6,335,000
+6,210,000
| +4,968% | +$48M | 0.23% | 106 |
|
|
2020
Q4 | $819K | Buy |
+125,000
| New | +$819K | ﹤0.01% | 776 |
|
|
2020
Q3 | – | Sell |
-1,033,406
| Closed | -$8.61M | – | 894 |
|
|
2020
Q2 | $8.61M | Buy |
1,033,406
+816,842
| +377% | +$6.8M | 0.06% | 355 |
|
|
2020
Q1 | $1.66M | Sell |
216,564
-504,436
| -70% | -$3.87M | 0.01% | 497 |
|
|
2019
Q4 | $5.99M | Buy |
+721,000
| New | +$5.99M | 0.03% | 440 |
|
|
2019
Q3 | – | Sell |
-330,498
| Closed | -$3.71M | – | 1116 |
|
|
2019
Q2 | $3.71M | Sell |
330,498
-295,151
| -47% | -$3.31M | 0.02% | 494 |
|
|
2019
Q1 | $6.73M | Sell |
625,649
-838,147
| -57% | -$9.01M | 0.03% | 427 |
|
|
2018
Q4 | $22.1M | Buy |
1,463,796
+136,056
| +10% | +$2.05M | 0.11% | 203 |
|
|
2018
Q3 | $24.6M | Buy |
1,327,740
+1,169,569
| +739% | +$21.6M | 0.1% | 191 |
|
|
2018
Q2 | $3.62M | Buy |
+158,171
| New | +$3.62M | 0.01% | 537 |
|